134 related articles for article (PubMed ID: 11515856)
1. Chronic diarrhea: to scope or not to scope?
Achkar JP
Inflamm Bowel Dis; 2001 Aug; 7(3):276-7. PubMed ID: 11515856
[No Abstract] [Full Text] [Related]
2. Age-dependent variations in fecal calprotectin concentrations in children.
Rugtveit J; Fagerhol MK
J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):323-4; author reply 324-5. PubMed ID: 11964964
[No Abstract] [Full Text] [Related]
3. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
Limburg PJ; Ahlquist DA; Sandborn WJ; Mahoney DW; Devens ME; Harrington JJ; Zinsmeister AR
Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
[TBL] [Abstract][Full Text] [Related]
4. Is fecal calprotectin the next standard in inflammatory bowel disease activity tests?
Alic M
Am J Gastroenterol; 1999 Nov; 94(11):3370-1. PubMed ID: 10566749
[No Abstract] [Full Text] [Related]
5. Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation.
Bjarnason I; Sherwood R
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):11-3. PubMed ID: 11479401
[No Abstract] [Full Text] [Related]
6. Faecal calprotectin levels and colorectal neoplasia.
Brydon WG; Campbell SS; Anderson NA; Wilson RG; Ghosh S
Gut; 2001 Apr; 48(4):579-80. PubMed ID: 11288736
[No Abstract] [Full Text] [Related]
7. Investigating young adults with chronic diarrhoea in primary care.
Chapman TP; Chen LY; Leaver L
BMJ; 2015 Feb; 350():h573. PubMed ID: 25716699
[No Abstract] [Full Text] [Related]
8. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease.
Mozdiak E; O'Malley J; Arasaradnam R
BMJ; 2015 Sep; 351():h4416. PubMed ID: 26403642
[No Abstract] [Full Text] [Related]
10. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
Gearry R; Barclay M; Florkowski C; George P; Walmsley T
N Z Med J; 2005 May; 118(1214):U1444. PubMed ID: 15886739
[No Abstract] [Full Text] [Related]
11. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
13. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hepatocyte growth factor as a local acute phase response marker in the bowel: the clinical impact of a rapid diagnostic test for immediate identification of acute bowel inflammation.
Sorour AE; Lönn J; Nakka SS; Nayeri T; Nayeri F
Cytokine; 2015 Jan; 71(1):8-15. PubMed ID: 25174881
[TBL] [Abstract][Full Text] [Related]
15. Calprotectin, a leukocyte protein related to inflammation, in gingival crevicular fluid.
Kido J; Nakamura T; Kido R; Ohishi K; Yamauchi N; Kataoka M; Nagata T
J Periodontal Res; 1998 Oct; 33(7):434-7. PubMed ID: 9842509
[No Abstract] [Full Text] [Related]
16. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm.
Husebye E; Tøn H; Johne B
Am J Gastroenterol; 2001 Sep; 96(9):2683-7. PubMed ID: 11569695
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
Ikhtaire S; Shajib MS; Reinisch W; Khan WI
J Gastroenterol; 2016 May; 51(5):434-46. PubMed ID: 26897740
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
[TBL] [Abstract][Full Text] [Related]
19. [The diagnosis of IBD must have a wide foundation].
Grip O; Halfvarson J; Carlson M; Sternby B
Lakartidningen; 2009 Nov 4-12; 106(45):2984-6. PubMed ID: 19998823
[No Abstract] [Full Text] [Related]
20. Immunoanalytical characteristics of fecal calprotectin.
Desbène C; Gaillard O; Kapel N
Ann Biol Clin (Paris); 2016 Dec; 74(6):725-734. PubMed ID: 27848924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
